US Stock MarketDetailed Quotes

QNRX Quoin Pharmaceuticals

Watchlist

0.2995
+0.0043+1.46%

Close Mar 19 16:00 ET

0.2957
-0.0038-1.27%

Post 20:01 ET

6.17MMarket Cap-0.16P/E (TTM)

Quoin Pharmaceuticals Stock Forum

Teddy123

Mar 13 19:38

Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results

$Quoin Pharmaceuticals (QNRX.US)$
Quoin's Netherton Treatment Shows Dramatic Results, Secures FDA Green Light

Teddy123

Mar 4 21:27

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications

$Quoin Pharmaceuticals (QNRX.US)$
Can Quoin's New Rapamycin Patents Transform Treatment for These Orphan Diseases?

browny_440

Mar 4 04:52

$Quoin Pharmaceuticals (QNRX.US)$
just keep holding still early days. all year long if we have to I'll never sell at a loss

Share Your Profit/Loss

IronM

Mar 1 08:49

$Quoin Pharmaceuticals (QNRX.US)$ Is this going to r.s.s any time, soon? Just curious

Smokey The Bear

Feb 28 17:19

$Quoin Pharmaceuticals (QNRX.US)$ 🫡

Teddy123

Feb 28 17:09

8k filed

$Quoin Pharmaceuticals (QNRX.US)$
Quoin Pharmaceuticals Ltd. (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announced highly positive clinical data from its ongoing Investigator Pediatric Netherton Syndrome (NS) study. Dramatic improvement was observed in the patient’s disease state with clear visual evidence of skin healing observed after just two weeks of whole-body application of QRX003.

Both key clinic...